Epizyme Inc. buy melinda
Start price
14.06.17
/
50%
€11.84
Target price
22.06.17
€16.24
Performance (%)
10.06%
End price
22.06.17
€13.03
Summary
This prediction ended on 22.06.17 with a price of €13.03. The prediction had a final performance of 10.06%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epizyme Inc. | - | - | - | - |
| iShares Core DAX® | -2,68 % | 2,02 % | 3,06 % | 56,11 % |
| iShares Nasdaq 100 | 0,73 % | 2,75 % | 34,40 % | 92,06 % |
| iShares Nikkei 225® | -0,73 % | 5,70 % | 63,75 % | 79,14 % |
| iShares S&P 500 | 1,17 % | 4,06 % | 25,14 % | 70,02 % |
Comments by melinda for this prediction
In the thread Epizyme Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
(Vom Mitglied beendet)